A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection.
Fabien ZoulimChristophe MorenoSamuel S LeePeter BuggischAndrzej HorbanEric LawitzChris CorbettOliver LenzBart FeveryThierry VerbinnenUmesh ShuklaWolfgang JessnerPublished in: Virology journal (2018)
NCT01349465; ClinicalTrials.gov .